Atlas Trials

A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001

Clinical trial NCT02096341 · TERMINATED

Trial details

NCT number
NCT02096341
Sponsor
EpicentRx, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant Solid TumorLymphomas
Start date
2014-04-01
Primary completion
2016-01-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.